Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

By Rebecca Robbins from NYT Health https://ift.tt/hLW9NTg
via IFTTT
Health
Appointments and Executive Changes, Drugs (Pharmaceuticals), Ozempic (Drug), GLP-1 RAs (Drug), Stocks and Bonds
New York Times
May 16, 2025 at 07:28PM